Legilait (Diosmin)

Diosmin acts as a venotonic and anti‑inflammatory agent. It strengthens the endothelial lining of veins, enhances smooth‑muscle contractility, reduces capillary permeability, and promotes lymphatic drainage, thereby improving microcirculation and decreasing edema.

The appropriate dose of Legilait is determined by the prescribing healthcare professional based on the individual’s condition, severity and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Diosmin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Legilait, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Legilait’s active ingredient, Diosmin, is a flavonoid with both venotonic and anti‑inflammatory properties. Compared with synthetic agents, Diosmin offers a natural profile, may have fewer systemic side effects, and is often combined with hesperidin for synergistic effect, though clinical choice depends on individual patient factors.

Legilait should be stored at ambient temperature, below 25 °C, in its original packaging. It must be kept away from moisture, direct sunlight and heat sources to maintain stability and potency.

Legilait is taken orally, usually with a glass of water. The exact administration schedule, such as frequency and duration, is prescribed by the treating clinician based on the patient’s specific condition.

Serious risks, though rare, include hypersensitivity reactions such as anaphylaxis, severe abdominal pain, hepatic dysfunction, and thrombocytopenia. Patients should seek immediate medical attention if they experience signs of an allergic reaction, unexplained liver issues or abnormal bleeding.

Legilait is contraindicated in individuals with known hypersensitivity to Diosmin or any excipients in the formulation. It should also be avoided in patients with severe hepatic impairment or active bleeding disorders unless specifically directed by a physician.